http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101590842-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate | 2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101590842-B1 |
titleOfInvention | Aster glehni extracts, fractions or compounds isolated therefrom for the treatment or prevention of Hyperuricemia or Gout |
abstract | The present invention relates to Aster glehni extract, fractions thereof and active compounds isolated therefrom, which are effective for the treatment, prevention and amelioration of hyperlipidemia or gout. Island of the present invention ridden Aster (Aster glehni) extracts, as the active compound isolated from its fractions, and the fractions 6'- O - M-flops when a cafe five days siohno side (6'- O -caffeoylampelopsisionoside), 6'- O - a cafe five days Seo side (6'- O -caffeoylroseoside), 6'- O - five days cafe hand side Tsui Ono seed (6'- O -caffeoylsonchuinoside C), 6'- O - cafe five days dihydro ache binary (6 ' - O- caffeoyldihydrosyringin), glehnoside (glehnoside) is effective in inhibiting the formation of uric acid and the concentration-decreasing effect. Accordingly, the Aster glehni extract of the present invention, its fractions, and the active compounds isolated from the fractions are diseases caused by an increase in the concentration of uric acid, such as drugs, which require treatment, prevention and improvement of hyperuricemia or gout, It can be usefully used as an active ingredient such as food. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018066952-A1 |
priorityDate | 2014-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.